U.S. Glaucoma Pharmaceuticals Market
U.S. Glaucoma Pharmaceuticals Market
RELEASE DATE
26-Mar-2009
26-Mar-2009
REGION
North America
North America
Research Code: N5D8-01-00-00-00
SKU: HC02120-NA-MR_07631
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC02120-NA-MR_07631
Description
This research service explores the market for prescription ophthalmics used for the treatment of glaucoma in the United States of America. It analyzes the various challenges faced by pharmaceutical and biotech companies, and the competitive advantages and disadvantages of their products in the market.
Table of Contents
Executive Summary
- Overview
Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
Market Overview
- Introduction
- Disease Overview
Patient Forecasts
- Ocular Hypertension
- Open-Angle Glaucoma
Market Trends
- Industry Challenges and Strategies
- Market Drivers
Approved Therapies and Treatment Overview
Pipeline Analysis
Introduction
Market Share and Revenue Forecasts
Decision Support Databases
Related Research
Popular Topics
This research service explores the market for prescription ophthalmics used for the treatment of glaucoma in the United States of America. It analyzes the various challenges faced by pharmaceutical and biotech companies, and the competitive advantages and disadvantages of their products in the market.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | N5D8-01-00-00-00 |
Is Prebook | No |